Choroidal neovascularization (CNV) in late stage age-related macular degeneration (AMD) involves abnormal vessel growth from the choriocapillaris through Bruch’s membrane and the retinal pigment epithelium (RPE) and accounts for more than 80%of the severe debilitating vision loss in all AMD patients. The molecular mechanisms associated with AMD pathogenesis and the development of CNV remain poorly understood.We hypothesize that oxidative protein modifications are primary catalysts in AMD pathogenesis and play a role in the development of CNV (Crabb et al., 2002). Oxidative damage has long been suspected of contributing to AMD (Beatty et al., 2000), supported by indirect evidence that smoking increases the risk of AMD (Seddon et al., 1996) and that antioxidant vitamins and zinc can slow disease progression for select individuals (AREDS, 2001).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
AREDS (2001). “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss: Areds report no. 8.” Arch Ophthalmol 119: 1417.
Beatty, S., H. Koh, M. Phil, D. Henson and M. Boulton (2000). “The role of oxidative stress in the pathogenesis of age-related macular degeneration.” Surv Ophthalmol 45: 115.
Crabb, J. W., M. Miyagi, X. Gu, K. Shadrach, K. A. West, H. Sakaguchi, M. Kamei, A. Hasan, L. Yan, M. E. Rayborn, R. G. Salomon and J. G. Hollyfield (2002). “Drusen proteome analysis: An approach to the etiology of age-related macular degeneration.” Proc Natl Acad Sci U S A 99: 14682.
Dewan, A., M. Liu, S. Hartman, S. S. Zhang, D. T. Liu, C. Zhao, P. O. Tam, W. M. Chan, D. S. Lam, M. Snyder, C. Barnstable, C. P. Pang and J. Hoh (2006). “Htra1 promoter polymorphism in wet age-related macular degeneration.” Science 314: 989.
Ebrahem, Q., K. Renganathan, J. Sears, A. Vasanji, X. Gu, L. Lu, R. G. Salomon, J. W. Crabb and B. Anand-Apte (2006). “Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration.” Proc Natl Acad Sci U S A 103: 13480.
Edwards, A. O., R. Ritter, 3rd, K. J. Abel, A. Manning, C. Panhuysen and L. A. Farrer (2005). “Complement factor h polymorphism and age-related macular degeneration.” Science 308: 421.
Fliesler, S. J. and R. E. Anderson (1983). “Chemistry and metabolism of lipids in the vertebrate retina.” Prog Lipid Res 22: 79.
Gold, B., J. E. Merriam, J. Zernant, L. S. Hancox, A. J. Taiber, K. Gehrs, K. Cramer, J. Neel, J. Bergeron, G. R. Barile, R. T. Smith, G. S. Hageman, M. Dean and R. Allikmets (2006). “Variation in factor b (bf) and complement component 2 (c2) genes is associated with age-related macular degeneration.” Nat Genet 38: 458.
Gragoudas, E. S., A. P. Adamis, E. T. Cunningham, Jr., M. Feinsod and D. R. Guyer (2004). “Pegaptanib for neovascular age-related macular degeneration.” N Engl J Med 351: 2805.
Gu, X., S. G. Meer, M. Miyagi, M. Rayborn, J. G. Hollyfield, J. W. Crabb and R. G. Salomon (2003). “Carboxyethylpyrrole proein adducts and autoantibodies, biomarkers for age-related macular degeneration.” J. Biol. Chem. 278: 42027.
Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, R. J. Smith, G. Silvestri, S. R. Russell, C. C. Klaver, I. Barbazetto, S. Chang, L. A. Yannuzzi, G. R. Barile, J. C. Merriam, R. T. Smith, A. K. Olsh, J. Bergeron, J. Zernant, J. E. Merriam, B. Gold, M. Dean and R. Allikmets (2005). “A common haplotype in the complement regulatory gene factor h (hf1/cfh) predisposes individuals to age-related macular degeneration.” Proc Natl Acad Sci U S A 102: 7227.
Haines, J. L., M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E. A. Postel and M. A. Pericak-Vance (2005). “Complement factor h variant increases the risk of age-related macular degeneration.” Science 308: 419.
Handa, J. T., N. Verzijl, H. Matsunaga, A. Aotaki-Keen, G. A. Lutty, J. M. te Koppele, T. Miyata and L. M. Hjelmeland (1999). “Increase in the advanced glycation end product pentosidine in bruch’s membrane with age.” Invest Ophthalmol Vis Sci 40: 775.
Hirata, C., K. Nakano, N. Nakamura, Y. Kitagawa, H. Shigeta, G. Hasegawa, M. Ogata, T. Ikeda, H. Sawa, K. Nakamura, K. Ienaga, H. Obayashi and M. Kondo (1997). “Advanced glycation end products induce expression of vascular endothelial growth factor by retinal muller cells.” Biochem Biophys Res Commun 236: 712.
Hoffmann, S., R. Masood, Y. Zhang, S. He, S. J. Ryan, P. Gill and D. R. Hinton (2000). “Selective killing of rpe with a vascular endothelial growth factor chimeric toxin.” Invest Ophthalmol Vis Sci 41: 2389.
Imamura, Y., S. Noda, K. Hashizume, K. Shinoda, M. Yamaguchi, S. Uchiyama, T. Shimizu, Y. Mizushima, T. Shirasawa and K. Tsubota (2006). “Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in sod1-deficient mice: A model of age-related macular degeneration.” Proc Natl Acad Sci U S A 103: 11282.
Ishibashi, T., T. Murata, M. Hangai, R. Nagai, S. Horiuchi, P. F. Lopez, D. R. Hinton and S. J. Ryan (1998). “Advanced glycation end products in age-related macular degeneration.” Arch Ophthalmol 116: 1629.
Jakobsdottir, J., Y. P. Conley, D. E. Weeks, T. S. Mah, R. E. Ferrell and M. B. Gorin (2005). “Susceptibility genes for age-related maculopathy on chromosome 10q26.” Am J Hum Genet 77: 389.
Klein, R. J., C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, M. B. Bracken, F. L. Ferris, J. Ott, C. Barnstable and J. Hoh (2005). “Complement factor h polymorphism in age-related macular degeneration.” Science 308: 385.
Lewin, A. S., V. Justilien, J. Pang, W. W. Hauswirth, J. W. Crabb, N. Renganathan, S. R. Kim and J. R. Sparrow (2007). “Modeling early stages of age-related macular degeneration (amd) by inducing oxidative stress in the rpe ” Invest Opthalmol Vis Sci, E-abstract 5055.
Malek, G., L. V. Johnson, B. E. Mace, P. Saloupis, D. E. Schmechel, D. W. Rickman, C. A. Toth, P. M. Sullivan and C. B. Rickman (2005). “Apolipoprotein e allele-dependent pathogenesis: A model for age-related retinal degeneration.” Proc Natl Acad Sci U S A 102: 11900.
Okamoto, T., S. Tanaka, A. C. Stan, T. Koike, M. Kase, Z. Makita, H. Sawa and K. Nagashima (2002). “Advanced glycation end products induce angiogenesis in vivo.” Microvasc Res 63: 186.
Rivera, A., S. A. Fisher, L. G. Fritsche, C. N. Keilhauer, P. Lichtner, T. Meitinger and B. H. Weber (2005). “Hypothetical loc387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor h to disease risk.” Hum Mol Genet 14: 3227.
Rosenfeld, P. J., S. D. Schwartz, M. S. Blumenkranz, J. W. Miller, J. A. Haller, J. D. Reimann, W. L. Greene and N. Shams (2005). “Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.” Ophthalmology 112: 1048.
Seddon, J. M., W. C. Willett, F. E. Speizer and S. E. Hankinson (1996). “A prospective study of cigarette smoking and age-related macular degeneration in women.” J Am Med Assoc 276: 1141.
Wu, J. T. (1993). “Advanced glycosylation end products: A new disease marker for diabetes and aging.” J Clin Lab Anal 7: 252.
Yang, Z., N. J. Camp, H. Sun, Z. Tong, D. Gibbs, D. J. Cameron, H. Chen, Y. Zhao, E. Pearson, X. Li, J. Chien, A. Dewan, J. Harmon, P. S. Bernstein, V. Shridhar, N. A. Zabriskie, J. Hoh, K. Howes and K. Zhang (2006). “A variant of the htra1 gene increases susceptibility to age-related macular degeneration.” Science 314: 992.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Renganathan, K. et al. (2008). Carboxyethylpyrrole Adducts, Age-related Macular Degeneration and Neovascularization. In: Anderson, R.E., LaVail, M.M., Hollyfield, J.G. (eds) Recent Advances in Retinal Degeneration. Advances in Experimental Medicine and Biology, vol 613. Springer, New York, NY. https://doi.org/10.1007/978-0-387-74904-4_30
Download citation
DOI: https://doi.org/10.1007/978-0-387-74904-4_30
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-74902-0
Online ISBN: 978-0-387-74904-4
eBook Packages: MedicineMedicine (R0)